DSpace

DSpace at RU >

Browsing by Author Davidson, R.

Jump to a point in the index:
Or type in a year:
Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 17 of 17
Full TextIssue DateTitleAuthor(s)
2012Gene-gene interactions in breast cancer susceptibility.Turnbull, C.; Seal, S.; Renwick, A.; Warren-Perry, M.; Hughes, D., et al
2012Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriersAntoniou, A.C.; Kuchenbaecker, K.B.; Soucy, P.; Beesley, J.; Chen, X, et al
2012Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersCouch, F.J.; Gaudet, M.M.; Antoniou, A.C.; Ramus, S.J.; Kuchenbaecker, K.B., et al
2012A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers.Ding, Y.C.; McGuffog, L.; Healey, S.; Friedman, E.; Laitman, Y., et al
2012Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriersRamus, S.J.; Antoniou, A.C.; Kuchenbaecker, K.B.; Soucy, P.; Beesley, J., et al
2012Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2.Kirchhoff, T.; Gaudet, M.M.; Antoniou, A.C.; McGuffog, L.; Humphreys, M.K., et al
2012Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.Jakubowska, A.; Rozkrut, D.; Antoniou, A.; Hamann, U.; Scott, R.J., et al
2011Exploring the link between MORF4L1 and risk of breast cancer.Martrat, G.; Maxwell, C.M.; Tominaga, E.; Porta-de-la-Riva, M.; Bonifaci, N., et al
2011Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriersSpurdle, A.B.; Marquart, L.; McGuffog, L.; Healey, S.; Sinilnikova, O., et al
2011Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2Osorio, A.; Milne, R.L.; Alonso, R.; Pita, G.; Peterlongo, P., et al
2011Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriersAntoniou, A.C.; Kartsonaki, C.; Sinilnikova, O.M.; Soucy, P.; McGuffog, L., et al
2011Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2Mulligan, A.M.; Couch, F.J.; Barrowdale, D.; Domchek, S.M.; Eccles, D., et al
2009No evidence that GATA3 rs570613 SNP modifies breast cancer risk.Johnatty, S.E.; Couch, F.J.; Fredericksen, Z.; Tarrell, R.; Spurdle, A.B., et al
2009Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.Antoniou, A.C.; Sinilnikova, O.M.; McGuffog, L.; Healey, S.; Nevanlinna, H., et al
2008Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.Antoniou, A.C.; Spurdle, A.B.; Sinilnikova, O.M.; Healey, S.; Pooley, K.A., et al
2008Variable phenotypes associated with 10q23 microdeletions involving the PTEN and BMPR1A genes.Menko, F.H.; Kneepkens, C.M.; Leeuw, N. de; Peeters, E.A.; Maldergem, L Van, et al
2007Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study.Chang-Claude, J.; Andrieu, N.; Rookus, M.A.; Brohet, R.M.; Antoniou, A.C., et al
Showing results 1 to 17 of 17

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback